trial
as of 2026-07-01Enhancement of Treatment of Delusions in Schizophrenia Through Neuromodulation
NCTId NCT03062553
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of British Columbia
Primary completion 2020-12-15
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-02-01
Primary completion
2020-12-15
Eligibility
ALL · 19 Years · 60 Years
Interventions & indications
Sponsors
University of British ColumbiaLead Sponsor
Vancouver Coastal Health Research InstituteCollaborator
Brain & Behavior Research FoundationCollaborator
Investigators
1
Todd S Woodward, PhDPrincipal Investigator
Sites
1 total
Vancouver, Canada
Facts & assertions
4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2020-12-15
Status
WITHDRAWN
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator
person